B Rada
About
In The Last Decade
B Rada
34 papers receiving 322 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 127
- Infectious Diseases 126
- Epidemiology 94
- Organic Chemistry 62
- Genetics 56
Countries citing papers authored by B Rada
This map shows the geographic impact of B Rada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Rada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Rada more than expected).
Fields of papers citing papers by B Rada
This network shows the impact of papers produced by B Rada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Rada. The network helps show where B Rada may publish in the future.
Co-authorship network of co-authors of B Rada
This figure shows the co-authorship network connecting the top 25 collaborators of B Rada. A scholar is included among the top collaborators of B Rada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Rada. B Rada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Pharmacology of antimicrobials used in the treatment of serious Gram-positive bacteria infections]. | 1 |
| 2 | Antiviral activities of pyrimidine nucleoside analogues: some structure--activity relationships. | 9 |
| 3 | 5 | |
| 4 | 3 | |
| 5 | Antiviral activity of benzothiazole and benzothiazolinethione derivatives in cell cultures. | 8 |
| 6 | Inhibition of Newcastle disease virus replication by 6-azauridine. I. Inefficacy of purified uridine kinase, effect of adenosine-5'-triphosphate. | 0 |
| 7 | Inhibition of Newcastle disease virus replication by 6-azauridine. II. Combination of 6-azauridine and adenine derivatives. | 1 |
| 8 | Uridine kinase: properties, biological significance and chemotherapeutic aspects (a review). | 24 |
| 9 | Inhibition of replication of some RNA viruses by 6-azauridine. | 3 |
| 10 | 1 | |
| 11 | Virus-inhibitory activity of 6-azauridine dependent on cell-free extracts containing uridine kinase. II. Quantitative aspects, efficacy of pretreatment. | 1 |
| 12 | 10 | |
| 13 | THE INHIBITORY EFFECT OF SOME ANTIMETABOLITES AND ANTIBIOTICS ON ROUS SARCOMA GROWTH. | 3 |
| 14 | 9 | |
| 15 | 1 | |
| 16 | ANTIVIRAL AND COFACTOR-LIKE ACTIVITIES OF SOME DEXTRAN SULFATES. | 2 |
| 17 | Studies on the Effect of Antiviral Substances on Experimental Virus Infections. III. The Effects of 6-Azauracil Riboside and Urethane on Vaccinia Virus Infection in Mice. | 3 |
| 18 | Synthesis of cellular nucleic acids during inhibition of vaccinia virus multiplication by 6-azauracil riboside. | 2 |
| 19 | Screening-test for cytostatic and virostatic substances. | 14 |
| 20 | Inhibition of Vaccinia Virus Multiplication in vitro by 6-Azauracil Riboside. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.